Concepedia

Michelle Archer

MA

7

Publications

439

Citations

7

H-Index

2018

Active since

Affiliations

Infectious Disease Research Institute(Current)

University of Washington

University of Alberta

Michelle Archer is an author at Infectious Disease Research Institute specializing in vaccination, nanomedicine, and tuberculosis.

Top concepts

Publications per year

2018–2022

7

Publications

7

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika

Jesse H. Erasmus, Amit P. Khandhar, Jeff Guderian et al. · Molecular Therapy · 2018 · 166 citations · Full text

A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery

Alana Gerhardt, Emily A. Voigt, Michelle Archer et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 77 citations · Full text

Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate

Mellissa Gomez, Joseph McCollum, Hui Wang et al. · International Journal of Pharmaceutics · 2020 · 58 citations · Full text

, , +7

Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses

Emilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert et al. · The Journal of Immunology · 2018 · 47 citations · Full text

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach

Ryan M. Kramer, Michelle Archer, Mark T. Orr et al. · International Journal of Nanomedicine · 2018 · 42 citations · Full text

Rows per page

1–5 of 7